Nomination committee

Dicot Pharma’s Nomination Committee is responsible for preparing and presenting proposals for the next Annual General Meeting. Its mandate includes proposals for the Chairman of the Board, Board members, Board remuneration (broken down by the Chairman, members, and any committees), the Chairman of the Annual General Meeting, auditor fees, and the election of auditors. The Nomination Committee’s proposals are submitted in conjunction with the notice of the upcoming Annual General Meeting.

The Nomination Committee has now been appointed and consists of the following three members:

• Göran Beijer, appointed by Bertil Lindkvist
• Carl Leijonhufvud
• Tore Robertsson, representing Tor Finans AB

Tore Robertsson has been appointed Chair of the Nomination Committee. He has asked Eva Sjökvist Saers, Chair of the Board, to convene the Nomination Committee. No remuneration will be paid to the members of the Nomination Committee.

The Nomination Committee’s proposals will be presented in connection with the notice of the forthcoming Annual General Meeting. The Nomination Committee is responsible for preparing and presenting proposals for the Chair of the Board, Board members and the Chair of the Annual General Meeting, as well as for the election of auditors. Its remit also includes proposals for Board remuneration, allocated between the Chair, members and any committees, as well as remuneration of the auditors.

Shareholders’ proposals should reach the Nomination Committee no later than December 18, 2026 to allow them to be considered constructively. Proposals should be submitted by email to [email protected].

Dicot Pharma’s 2027 Annual General Meeting will be held on Tuesday, May 4, 2027 at 5:00 p.m. in Uppsala.

For further information, please contact:
Eva Sjökvist Saers, Chair of the Board
Telephone: +46 70 550 7371
Email: [email protected]